Show
Sort by
-
Management of patients with chronic rhinosinusitis during the COVID-19 pandemic : an EAACI position paper
-
Efficacy and safety of treatment with biologicals for severe chronic rhinosinusitis with nasal polyps : a systematic review for the EAACI guidelines
-
Personalized medicine for allergy treatment : allergen immunotherapy still a unique and unmatched model
-
COVID‐19 pandemic : practical considerations on the organization of an allergy clinic : an EAACI/ARIA position paper
-
Differentiation of COVID‐19 signs and symptoms from allergic rhinitis and common cold : an ARIA‐EAACI‐GA(2)LEN consensus
-
- Journal Article
- A1
- open access
ARIA-EAACI statement on asthma and COVID-19 (June 2, 2020)
-
- Journal Article
- A1
- open access
Management of anaphylaxis due to COVID‐19 vaccines in the elderly
-
- Journal Article
- A1
- open access
ARIA‐EAACI care pathways for allergen immunotherapy in respiratory allergy
-
ARIA digital anamorphosis : digital transformation of health and care in airway diseases from research to practice
-
Cabbage and fermented vegetables : from death rate heterogeneity in countries to candidates for mitigation strategies of severe COVID-19